Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed chronic lymphocytic leukemia Meeting Abstract
| Authors: | Pagel, J. M.; Coutre, S. E.; Furman, R. R.; Sharman, J. P.; Cheson, B. D.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; Ghia, P.; Eradat, H. A.; Ervin, T.; Lamanna, N.; Coiffier, B.; Pettitt, A.; Li, X. M.; Jahn, T. M.; O'Brien, S. M.; Hallek, M. J. |
| Abstract Title: | Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed chronic lymphocytic leukemia |
| Meeting Title: | 2nd Annual Meeting of the Society of Hematalogic Oncology (SOHO 2014) |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 15 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2014 Sep 17-20 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-06-01 |
| Start Page: | S201 |
| End Page: | S202 |
| Language: | English |
| ACCESSION: | WOS:000370676300086 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.clml.2015.04.062 |
| Notes: | Meeting Abstract: 302 -- Source: Wos |
